Effect of neoadjuvant chemotherapy regimen on relapse-free survival among patients with breast cancer achieving a pathologic complete response: an early step in the de-escalation of neoadjuvant chemotherapy

BACKGROUND: Patients with breast cancer who have a pathologic complete response (pCR) to neoadjuvant chemotherapy (NACT) have improved survival. We hypothesize that once pCR has been achieved, there is no difference in subsequent postsurgical recurrence-free survival (RFS), whichever NACT regimen is...

Descripción completa

Detalles Bibliográficos
Autores principales: Weiss, Anna, Bashour, Sami I., Hess, Kenneth, Thompson, Alastair M., Ibrahim, Nuhad K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5902970/
https://www.ncbi.nlm.nih.gov/pubmed/29661243
http://dx.doi.org/10.1186/s13058-018-0945-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5902970/
https://www.ncbi.nlm.nih.gov/pubmed/29661243
http://dx.doi.org/10.1186/s13058-018-0945-7

Ejemplares similares